Amicus Therapeutics (FOLD) SEC Filings & 10K Form

$10.28
+0.11 (+1.08%)
(As of 04/26/2024 ET)

Recent Amicus Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2024
3:31 PM
Amicus Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:32 PM
Amicus Therapeutics (Filer)
Form DEFA14A
04/16/2024
4:42 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
4:52 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:12 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4/A
03/15/2024
6:13 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4/A
03/15/2024
6:14 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4/A
03/15/2024
6:15 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4/A
03/15/2024
6:10 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4/A
03/11/2024
4:36 PM
Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:21 PM
Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:22 PM
Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:39 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:33 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:02 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
4:21 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:23 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:22 AM
Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
02/08/2024
3:40 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:22 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:22 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:44 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
3:45 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
4:20 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:18 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
4:09 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:25 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/11/2024
5:33 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:35 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:35 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:06 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
5:07 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:08 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:27 PM
Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
These AI trades triggered this morning (545% return) (Ad)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy
01/09/2024
3:27 PM
Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:09 AM
Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
01/08/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
5:01 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:01 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:02 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:03 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:03 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:04 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:24 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:26 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:33 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:35 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:36 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:17 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:30 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:32 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
3:32 PM
Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
4:18 PM
Amicus Therapeutics (Issuer)
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:08 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:09 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:21 PM
Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:25 PM
Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:25 PM
Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
3:41 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:20 PM
Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
4:54 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:55 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:56 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:58 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:37 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2023
3:31 PM
Amicus Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
12/05/2023
4:03 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:07 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:03 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
4:23 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:25 PM
Amicus Therapeutics (Filer)
Form S-3ASR
11/08/2023
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
6:37 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:38 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
6:57 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:23 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/05/2023
4:00 PM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
5:58 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
5:57 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:11 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
3:13 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
7:48 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
11:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Gold Grab of the Century (Ad)

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.
09/18/2023
4:09 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:10 PM
Amicus Therapeutics (Subject)
Quimi Daphne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:13 PM
Amicus Therapeutics (Subject)
Quimi Daphne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
4:29 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:31 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:11 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
4:46 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
4:59 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FOLD) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners